Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pancreatic enzyme replacement therapy in older adults with type 2 diabetes and exocrine pancreatic insufficiency
MOH_2021-12-02_010441Phase 4Not yet recruiting
- Sponsor
- יוסף שוקחה
- Start
- Oct 2021
- Modality
- Replacement Enzymes → Therapeutic Enzymes → Recombinant Proteins and Enzymes, Blood Coagulation Factors → Therapeutic Enzymes → Recombinant Proteins and Enzymes, Insulin and Analogs → Hormones & Growth Factors → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of pancreatin in exocrine pancreatic insufficiency (EPI), sponsored by יוסף שוקחה. Primary endpoints: Effect of pancreatic enzyme replacement on quality of life, Effect of pancreatic enzyme replacement on gastrointestinal symptoms and 1 more. Planned start Oct 2021; status: not yet recruiting.
02
Drugs
pancreatin
03
Conditions
exocrine pancreatic insufficiency (EPI)
Beyond the preview
Go deeper on MOH_2021-12-02_010441.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on MOH_2021-12-02_010441.